Figure 1. Schematic description of synchronous in vivo phage display screening. In every selection round, phage are intravenously (i.v.) administered and simultaneously recovered from N target tissues, amplified, pooled, and used for the next selection round. Increased recovery of phage transforming units (TU) in the third round reflects the selection of peptides preferentially homing to the target organ.